Skip to content

A clinical trail to know the efficacy of Homoeopathic medicine as an adjuvant therapy to Standard treatment in COVID-19 patients

A Proposal On An Evaluation On Effectiveness Of Homoeopathic Intervention As An Add On Therapy In The Management Of Covid 19 Infection – An Open Label Prospective Single Arm Observational Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/028164
Enrollment
50
Registered
2020-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B25-B34- Other viral diseases Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 3: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: indicated Homoeopathic Medicine: Four Globules thrice daily in oral route until recovery of the patient Control Intervention1: Not applicable: Not applicable

Sponsors

National institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Hospitalized patients with confirmed COVID-19 with a clinical categorization of mild and moderate 2. Age between 18 years to 80 years of both gender

Exclusion criteria

Exclusion criteria: 1. Patients with severe or critical COVID-19 infection. 2. Persons with severe primary respiratory disease or other pneumonia 3. Pregnant women 4. Persons with severe medical conditions requiring intensive managements 5. COVID-19 positive cases participating as subjects in the interventional arm of other COVID-19 clinical trials 6. Patients who have received organ transplantation in the past 6 months or planning surgery. 7. Patients with complications of Diabetes, Severe Heart, Liver, kidney, brain, blood disease. 8. Patients with any active malignancy. 9. Septicemia/Multi organ failure syndrome.

Design outcomes

Primary

MeasureTime frame
Symptomatic Betterment,Sign betterment,NLR Ratio & X-Ray finding before and after treatment Timepoint: one month

Secondary

MeasureTime frame
Laboratory investigation like NLR Ratio & X-Ray finding before and after treatment Timepoint: one month

Countries

India

Contacts

Public ContactDr Nithiyaselvi

National Institute of Homoeopathy

drrajanih@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026